Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Encino. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Encino at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
The primary purpose of this study is to evaluate the safety and durability of single- and repeat administration of AR-14034 Sustained Release (SR) in subjects with neovascular age-related macular degeneration (nAMD).
Sponsor: Alcon Research
Check if you qualify for this macular degeneration clinical trial in Encino, CA
If you're searching for macular degeneration treatment options in Encino, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Encino research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.